Reported obstructive sleep apnea does not diminish the cardiometabolic health benefits from a comprehensive lifestyle intervention program
Autor: | Patrick Walden, Robert W. Godley, Robert D. Brook, Melvyn Rubenfire, Peter Farrehi, Qingmei Jiang |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
Blood Glucose Male medicine.medical_specialty Sleep Apnea Waist Non-Randomized Controlled Trials as Topic Endocrinology Diabetes and Metabolism Diastole Blood Pressure 030204 cardiovascular system & hematology Body Mass Index 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Behavior Therapy Internal medicine Lifestyle intervention Internal Medicine medicine Humans Prospective Studies Triglycerides Metabolic Syndrome Sleep Apnea Obstructive Anthropometry Triglyceride business.industry Middle Aged medicine.disease Obstructive sleep apnea Blood pressure chemistry Female Metabolic syndrome Cardiology and Cardiovascular Medicine business Risk Reduction Behavior Body mass index 030217 neurology & neurosurgery |
Zdroj: | J Clin Hypertens (Greenwich) |
ISSN: | 1524-6175 |
DOI: | 10.1111/jch.13406 |
Popis: | Obstructive sleep apnea (OSA) commonly coexists with the metabolic syndrome, a condition for which behavioral changes are often prescribed. Whether OSA diminishes the cardiometabolic health benefits from lifestyle interventions remains unclear. We evaluated 278 consecutive metabolic syndrome participants enrolled in a 12‐week comprehensive lifestyle intervention program. The changes in blood pressure (BP), along with other metabolic health parameters, from baseline to follow‐up were compared between those with and without OSA. Mean age was 52.4 ± 10.9 years and 37% were male. At enrollment, mean body mass index (BMI) was 38.2 ± 7.7 kg/m(2). OSA was reported in 126 of 269 final participants (47%). At baseline, participants with reported OSA were more likely to be male, older, have a higher BMI, waist and neck size (all P |
Databáze: | OpenAIRE |
Externí odkaz: |